{"nct_id":"NCT01129349","title":"Phase 1 Study of Oprozomib Administered Orally in Patients With Advanced Refractory or Recurrent Solid Tumors","status":"COMPLETED","status_verified_date":"2017-04","start_date":"2010-04","start_date_type":null,"primary_completion_date":"2012-11","primary_completion_date_type":"ACTUAL","completion_date":"2013-03","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["AMGN"]}